output stringlengths 5 24.3k | instruction stringlengths 33 308 | system stringclasses 1 value |
|---|---|---|
1. Acarbose [adverse effects, *therapeutic use]; 2. Blood Glucose [*drug effects]; 3. Cause of Death; 4. Diabetes Mellitus, Type 2 [epidemiology, *prevention & control]; 5. Diet; 6. Exercise; 7. Fasting [*blood]; 8. Glucose Intolerance [*drug therapy]; 9. Glycoside Hydrolase Inhibitors [adverse effects, *therapeutic use]; 10. Incidence; 11. Inositol [adverse effects, *analogs & derivatives, therapeutic use]; 12. Metformin [adverse effects, therapeutic use]; 13. Prediabetic State [drug therapy]; 14. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Alpha‐glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus | You are a research assistant. Based on the question please provide appropriate answers |
1. *Inpatients; 2. Cause of Death; 3. Diabetes Mellitus, Type 2 [*drug therapy, mortality]; 4. Hypoglycemia [chemically induced]; 5. Hypoglycemic Agents [*administration & dosage, adverse effects]; 6. Insulin [*administration & dosage, adverse effects]; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Sliding scale insulin for non‐critically ill hospitalised adults with diabetes mellitus | You are a research assistant. Based on the question please provide appropriate answers |
1. Antibodies, Monoclonal, Humanized [*therapeutic use]; 2. Graves Ophthalmopathy [*drug therapy, immunology]; 3. Interleukin‐6 [*antagonists & inhibitors]; | Provide MESH terms for the study
Tocilizumab for thyroid eye disease | You are a research assistant. Based on the question please provide appropriate answers |
1. *Amputation, Surgical; 2. *Bandages [statistics & numerical data]; 3. Debridement; 4. Diabetic Foot [*surgery]; 5. Negative-Pressure Wound Therapy [adverse effects, *methods, statistics & numerical data]; 6. Randomized Controlled Trials as Topic; 7. *Wound Healing; | Provide MESH terms for the study
Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus | You are a research assistant. Based on the question please provide appropriate answers |
1. Diabetic Retinopathy [*complications]; 2. Laser Coagulation [*methods, statistics & numerical data]; 3. Lasers, Gas [therapeutic use]; 4. Macular Edema [etiology, *surgery]; 5. Randomized Controlled Trials as Topic; 6. Treatment Outcome; 7. Visual Acuity; | Provide MESH terms for the study
Monotherapy laser photocoagulation for diabetic macular oedema | You are a research assistant. Based on the question please provide appropriate answers |
1. Birth Weight; 2. Body Mass Index; 3. Hypertension [epidemiology]; 4. Hypoglycemic Agents [adverse effects, *therapeutic use]; 5. Metformin [adverse effects, *therapeutic use]; 6. *Obesity [complications]; 7. Overweight [complications]; 8. *Pregnancy Complications [epidemiology]; 9. Pregnancy Outcome; 10. Randomized Controlled Trials as Topic; 11. Weight Gain; | Provide MESH terms for the study
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes | You are a research assistant. Based on the question please provide appropriate answers |
1. Bevacizumab [*therapeutic use]; 2. Dexamethasone [*therapeutic use]; 3. Diabetic Retinopathy [*drug therapy, etiology, surgery]; 4. Drug Therapy, Combination [methods]; 5. Glucocorticoids [*therapeutic use]; 6. Intraocular Pressure; 7. Intravitreal Injections; 8. Macula Lutea [drug effects]; 9. Macular Edema [*drug therapy, etiology, surgery]; 10. Randomized Controlled Trials as Topic; 11. Ranibizumab [*therapeutic use]; 12. Receptors, Vascular Endothelial Growth Factor [antagonists & inhibitors]; 13. Triamcinolone [*therapeutic use]; 14. Vascular Endothelial Growth Factor A [*antagonists & inhibitors]; 15. Visual Acuity [drug effects]; | Provide MESH terms for the study
Anti‐vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema | You are a research assistant. Based on the question please provide appropriate answers |
1. Diabetic Retinopathy [*surgery]; 2. Laser Therapy [*methods]; 3. Lasers, Solid‐State [*therapeutic use]; 4. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Different lasers and techniques for proliferative diabetic retinopathy | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cesarean Section; 2. *Diabetes Mellitus, Type 1; 3. *Diabetes Mellitus, Type 2; 4. *Labor, Induced; 5. *Pregnancy in Diabetics; 6. *Term Birth; | Provide MESH terms for the study
Planned birth at or near term for improving health outcomes for pregnant women with pre‐existing diabetes and their infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *Diet; 2. *Exercise; 3. Cause of Death; 4. Combined Modality Therapy [methods]; 5. Diabetes Complications [prevention & control]; 6. Diabetes Mellitus, Type 2 [complications, epidemiology, *prevention & control]; 7. Diet, Diabetic; 8. Fasting [blood]; 9. Glucose Tolerance Test; 10. Incidence; 11. Randomized Controlled Trials as Topic; 12. Risk; | Provide MESH terms for the study
Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus | You are a research assistant. Based on the question please provide appropriate answers |
1. Adiposity [drug effects]; 2. Body Weight; 3. Cesarean Section [statistics & numerical data]; 4. Diabetes Mellitus, Type 2 [etiology]; 5. Diabetes, Gestational [*drug therapy]; 6. Fetal Macrosomia [epidemiology]; 7. Hypoglycemia [chemically induced]; 8. Hypoglycemic Agents [adverse effects, *therapeutic use]; 9. Insulin [adverse effects, *therapeutic use]; 10. Labor, Induced [statistics & numerical data]; 11. Pre-Eclampsia [prevention & control]; 12. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Insulin for the treatment of women with gestational diabetes | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Diabetes Mellitus [*drug therapy]; 3. Diabetes, Gestational [drug therapy]; 4. Glucose Intolerance [*drug therapy]; 5. Hypoglycemia [chemically induced]; 6. Hypoglycemic Agents [*administration & dosage]; 7. Insulin [therapeutic use]; 8. Metformin [therapeutic use]; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Oral anti‐diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre‐existing diabetes | You are a research assistant. Based on the question please provide appropriate answers |
1. Depression [*therapy]; 2. Diabetes Mellitus, Type 2 [blood, *psychology]; 3. Glycated Hemoglobin [metabolism]; 4. *Psychotherapy; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; 7. Self Care [psychology]; 8. Stress, Psychological [*therapy]; | Provide MESH terms for the study
Psychological interventions for diabetes‐related distress in adults with type 2 diabetes mellitus | You are a research assistant. Based on the question please provide appropriate answers |
1. *CD-ROM; 2. Diabetes Mellitus, Type 1 [blood, *therapy]; 3. Diabetes Mellitus, Type 2 [blood, *therapy]; 4. Glycated Hemoglobin [metabolism]; 5. Intention to Treat Analysis; 6. Patient Education as Topic [methods]; 7. Preconception Care [*methods]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Preconception care for diabetic women for improving maternal and infant health | You are a research assistant. Based on the question please provide appropriate answers |
1. Diabetic Foot [*therapy]; 2. Foot Ulcer [therapy]; 3. Phototherapy [adverse effects, *methods]; 4. Randomized Controlled Trials as Topic; 5. Wound Healing; | Provide MESH terms for the study
Phototherapy for treating foot ulcers in people with diabetes | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Topical; 2. Anti‐Bacterial Agents [*administration & dosage, adverse effects]; 3. Bacterial Infections [complications, *drug therapy, epidemiology]; 4. Bandages, Hydrocolloid; 5. Diabetic Foot [complications, *drug therapy]; 6. Foot Ulcer [drug therapy]; 7. Incidence; 8. Intercellular Signaling Peptides and Proteins [administration & dosage]; 9. Randomized Controlled Trials as Topic [statistics & numerical data]; 10. Wound Healing [drug effects]; | Provide MESH terms for the study
Topical antimicrobial agents for treating foot ulcers in people with diabetes | You are a research assistant. Based on the question please provide appropriate answers |
1. Albuminuria [epidemiology]; 2. *Blood Glucose; 3. Cardiovascular Diseases [mortality, prevention & control]; 4. Cause of Death; 5. Creatinine [blood]; 6. Death, Sudden [epidemiology]; 7. Diabetes Mellitus, Type 1 [complications]; 8. Diabetes Mellitus, Type 2 [complications]; 9. Diabetic Nephropathies [blood, *prevention & control]; 10. Disease Progression; 11. Fasting [*blood]; 12. *Glycated Hemoglobin [analysis]; 13. Hyperglycemia [blood, drug therapy]; 14. Hypoglycemic Agents [therapeutic use]; 15. Kidney Failure, Chronic [blood, etiology, *prevention & control]; 16. Myocardial Infarction [mortality, prevention & control]; 17. Randomized Controlled Trials as Topic; 18. Stroke [epidemiology, prevention & control]; 19. Time Factors; | Provide MESH terms for the study
Glucose targets for preventing diabetic kidney disease and its progression | You are a research assistant. Based on the question please provide appropriate answers |
1. Adamantane [analogs & derivatives, therapeutic use]; 2. Blood Glucose [metabolism]; 3. Diabetes Mellitus, Type 2 [complications, *prevention & control]; 4. Dipeptidyl-Peptidase IV Inhibitors [*therapeutic use]; 5. Exenatide; 6. Fasting; 7. Glucagon-Like Peptide 1 [*analogs & derivatives]; 8. Glucose Intolerance; 9. Glycated Hemoglobin [metabolism]; 10. Hypoglycemic Agents [therapeutic use]; 11. Incretins [*therapeutic use]; 12. Liraglutide [therapeutic use]; 13. Metformin [therapeutic use]; 14. Nitriles [therapeutic use]; 15. Peptides [therapeutic use]; 16. Pyrrolidines [therapeutic use]; 17. Randomized Controlled Trials as Topic; 18. Risk Factors; 19. Venoms [therapeutic use]; 20. Vildagliptin; | Provide MESH terms for the study
Dipeptidyl‐peptidase (DPP)‐4 inhibitors and glucagon‐like peptide (GLP)‐1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus | You are a research assistant. Based on the question please provide appropriate answers |
1. *Life Style; 2. Blood Glucose Self‐Monitoring; 3. Body Mass Index; 4. Body Weight; 5. Cesarean Section [statistics & numerical data]; 6. Depression, Postpartum [epidemiology]; 7. Diabetes Mellitus, Type 2 [etiology]; 8. Diabetes, Gestational [*therapy]; 9. Diet, Diabetic; 10. Exercise; 11. Infant, Postmature; 12. Labor, Induced [statistics & numerical data]; 13. Patient Education as Topic; 14. Perineum [injuries]; 15. Pre‐Eclampsia [epidemiology]; 16. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Lifestyle interventions for the treatment of women with gestational diabetes | You are a research assistant. Based on the question please provide appropriate answers |
1. Cause of Death; 2. Dietary Proteins [administration & dosage]; 3. *Dietary Supplements [adverse effects]; 4. Energy Intake; 5. Environment; 6. Hospitalization [statistics & numerical data]; 7. Malnutrition [*diet therapy, mortality]; 8. *Meals; 9. Nutritional Status; 10. Quality of Life; 11. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Supportive interventions for enhancing dietary intake in malnourished or nutritionally at‐risk adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Obesity Agents [adverse effects, *therapeutic use]; 2. Body Mass Index; 3. Cyclobutanes [therapeutic use]; 4. Fluoxetine [therapeutic use]; 5. Lactones [therapeutic use]; 6. Metformin [therapeutic use]; 7. Orlistat; 8. Pediatric Obesity [*drug therapy]; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Drug interventions for the treatment of obesity in children and adolescents | You are a research assistant. Based on the question please provide appropriate answers |
1. Benzamides [therapeutic use]; 2. Blood Glucose [analysis]; 3. Cardiovascular Diseases [mortality]; 4. Cyclohexanes [adverse effects, therapeutic use]; 5. Diabetes Mellitus, Type 2 [blood, mortality, *prevention & control]; 6. Fasting [blood]; 7. Hypoglycemic Agents [adverse effects, *therapeutic use]; 8. Insulin [*metabolism]; 9. Insulin Secretion; 10. Metformin [therapeutic use]; 11. Nateglinide; 12. Phenylalanine [adverse effects, analogs & derivatives, therapeutic use]; 13. Randomized Controlled Trials as Topic; 14. Sulfonylurea Compounds [adverse effects, *therapeutic use]; | Provide MESH terms for the study
Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus | You are a research assistant. Based on the question please provide appropriate answers |
1. Diabetes Mellitus, Type 1 [blood, *drug therapy]; 2. Hypoglycemia [chemically induced]; 3. Hypoglycemic Agents [adverse effects, *therapeutic use]; 4. Insulin [adverse effects, *therapeutic use]; 5. Insulin Aspart [*therapeutic use]; 6. Insulin Lispro [*therapeutic use]; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus | You are a research assistant. Based on the question please provide appropriate answers |
1. Anemia [therapy]; 2. Edible Grain; 3. *Food, Fortified; 4. Milk; 5. Randomized Controlled Trials as Topic; 6. Zinc [*administration & dosage, blood, *deficiency]; | Provide MESH terms for the study
Fortification of staple foods with zinc for improving zinc status and other health outcomes in the general population | You are a research assistant. Based on the question please provide appropriate answers |
1. *Insulin Infusion Systems; 2. *Pregnancy in Diabetics; 3. Birth Weight; 4. Diabetes Mellitus, Type 1 [*drug therapy]; 5. Hypoglycemic Agents [*administration & dosage]; 6. Injections, Subcutaneous; 7. Insulin [*administration & dosage]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes | You are a research assistant. Based on the question please provide appropriate answers |
1. *Platelet‐Rich Plasma; 2. *Wound Healing; 3. Blood Transfusion, Autologous [methods]; 4. Chronic Disease; 5. Diabetic Foot [*therapy]; 6. Platelet Transfusion [*methods]; 7. Randomized Controlled Trials as Topic; 8. Varicose Ulcer [*therapy]; | Provide MESH terms for the study
Autologous platelet‐rich plasma for treating chronic wounds | You are a research assistant. Based on the question please provide appropriate answers |
1. Blood Glucose [*metabolism]; 2. Diabetes Mellitus, Type 1 [blood, *therapy]; 3. Diabetes Mellitus, Type 2 [blood]; 4. Fasting [blood]; 5. Glycated Hemoglobin [metabolism]; 6. Hyperglycemia [blood, therapy]; 7. Hypoglycemic Agents [therapeutic use]; 8. Insulin [therapeutic use]; 9. Pregnancy in Diabetics [blood, *therapy]; 10. Randomized Controlled Trials as Topic; 11. Reference Values; | Provide MESH terms for the study
Different intensities of glycaemic control for pregnant women with pre‐existing diabetes | You are a research assistant. Based on the question please provide appropriate answers |
1. Diabetes Mellitus, Type 2 [psychology, *therapy]; 2. Mental Disorders [*complications]; 3. Randomized Controlled Trials as Topic; 4. Self Care [*methods]; | Provide MESH terms for the study
Self management interventions for type 2 diabetes in adult people with severe mental illness | You are a research assistant. Based on the question please provide appropriate answers |
1. Benzhydryl Compounds [therapeutic use]; 2. Diabetes Mellitus, Type 2 [complications, *prevention & control]; 3. Fasting [blood]; 4. Glucose Intolerance [blood, complications]; 5. Glucosides [therapeutic use]; 6. Glycated Hemoglobin; 7. Hypoglycemic Agents [therapeutic use]; 8. Metformin [therapeutic use]; 9. Risk Factors; 10. *Sodium-Glucose Transporter 2 Inhibitors; | Provide MESH terms for the study
Sodium‐glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus | You are a research assistant. Based on the question please provide appropriate answers |
1. Antithyroid Agents [*therapeutic use]; 2. Graves Disease [*therapy]; 3. Graves Ophthalmopathy [etiology]; 4. Iodine Radioisotopes [adverse effects, *therapeutic use]; 5. Methimazole [*therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Recurrence; | Provide MESH terms for the study
Radioiodine therapy versus antithyroid medications for Graves' disease | You are a research assistant. Based on the question please provide appropriate answers |
1. *Wound Healing; 2. Amputation, Surgical [statistics & numerical data]; 3. Diabetic Foot [*surgery]; 4. Foot Ulcer [surgery]; 5. Randomized Controlled Trials as Topic; 6. Skin Transplantation [adverse effects, *methods]; | Provide MESH terms for the study
Skin grafting and tissue replacement for treating foot ulcers in people with diabetes | You are a research assistant. Based on the question please provide appropriate answers |
1. Diabetic Ketoacidosis [*drug therapy]; 2. Hypoglycemic Agents [adverse effects, *therapeutic use]; 3. Injections, Subcutaneous; 4. Insulin [therapeutic use]; 5. Insulin Aspart [therapeutic use]; 6. Insulin Lispro [therapeutic use]; 7. Insulin, Short‐Acting [adverse effects, *therapeutic use]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Diabetes Mellitus, Type 1 [*complications]; 2. Diabetes Mellitus, Type 2 [*complications]; 3. Diabetic Foot [etiology, *therapy]; 4. Hyperglycemia [complications, *therapy]; | Provide MESH terms for the study
Intensive versus conventional glycaemic control for treating diabetic foot ulcers | You are a research assistant. Based on the question please provide appropriate answers |
1. Body Mass Index; 2. Body Weight; 3. Health Status; 4. Overweight [therapy]; 5. Parents [*education]; 6. Pediatric Obesity [*therapy]; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. Self Concept; | Provide MESH terms for the study
Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years | You are a research assistant. Based on the question please provide appropriate answers |
1. Graves Disease [*surgery]; 2. Graves Ophthalmopathy [surgery]; 3. Randomized Controlled Trials as Topic; 4. Recurrence; 5. Remission Induction [methods]; 6. Reoperation; 7. Secondary Prevention; 8. Thyroidectomy [adverse effects, *methods]; | Provide MESH terms for the study
Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy | You are a research assistant. Based on the question please provide appropriate answers |
1. Amputation, Surgical; 2. Diabetes Mellitus, Type 1 [*complications]; 3. Diabetes Mellitus, Type 2 [*complications]; 4. Diabetic Foot [*therapy]; 5. Growth Substances [adverse effects, *therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Wound Healing; | Provide MESH terms for the study
Growth factors for treating diabetic foot ulcers | You are a research assistant. Based on the question please provide appropriate answers |
1. Aromatase Inhibitors [adverse effects, *therapeutic use]; 2. Body Height [*drug effects]; 3. Estrogens [metabolism]; 4. Growth Disorders [*drug therapy]; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; 7. Testosterone [metabolism]; | Provide MESH terms for the study
Aromatase inhibitors for short stature in male children and adolescents | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Bacterial Agents [*therapeutic use]; 2. Bacterial Infections [*drug therapy]; 3. Carbapenems [therapeutic use]; 4. Cephalosporins [therapeutic use]; 5. Diabetic Foot [*drug therapy]; 6. Fluoroquinolones [therapeutic use]; 7. Penicillins [therapeutic use]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Systemic antibiotics for treating diabetic foot infections | You are a research assistant. Based on the question please provide appropriate answers |
1. Amputation, Surgical [*statistics & numerical data]; 2. Diabetic Foot [*prevention & control, surgery]; 3. Patient Education as Topic; 4. Randomized Controlled Trials as Topic; 5. Treatment Outcome; | Provide MESH terms for the study
Complex interventions for preventing diabetic foot ulceration | You are a research assistant. Based on the question please provide appropriate answers |
1. Goiter, Nodular [*surgery]; 2. Randomized Controlled Trials as Topic; 3. Recurrence; 4. Reoperation [statistics & numerical data]; 5. Thyroid Neoplasms [epidemiology]; 6. Thyroidectomy [adverse effects, *methods]; 7. Vocal Cord Paralysis [epidemiology]; | Provide MESH terms for the study
Total or near‐total thyroidectomy versus subtotal thyroidectomy for multinodular non‐toxic goitre in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. *Wound Healing; 2. Chronic Disease; 3. Diabetic Foot [*therapy]; 4. Hyperbaric Oxygenation [adverse effects]; 5. Randomized Controlled Trials as Topic; 6. Varicose Ulcer [*therapy]; | Provide MESH terms for the study
Hyperbaric oxygen therapy for chronic wounds | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Inflammatory Agents, Non‐Steroidal [*therapeutic use]; 2. Diabetic Retinopathy [complications, *drug therapy]; 3. Macular Edema [*drug therapy, etiology]; | Provide MESH terms for the study
Topical non‐steroidal anti‐inflammatory agents for diabetic cystoid macular oedema | You are a research assistant. Based on the question please provide appropriate answers |
1. Calcimimetic Agents [adverse effects, *therapeutic use]; 2. Calcium [blood]; 3. Cardiovascular Diseases [mortality]; 4. Cause of Death; 5. Cinacalcet; 6. Hyperparathyroidism, Secondary [blood, *drug therapy, etiology]; 7. Kidney Failure, Chronic [*complications, therapy]; 8. Naphthalenes [adverse effects, *therapeutic use]; 9. Parathyroid Hormone [blood]; 10. Phosphorus [blood]; 11. Randomized Controlled Trials as Topic; 12. Renal Dialysis; | Provide MESH terms for the study
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients | You are a research assistant. Based on the question please provide appropriate answers |
1. *Blood Glucose; 2. Diabetes Mellitus, Type 1 [blood, complications, *drug therapy]; 3. Diabetic Nephropathies [prevention & control]; 4. Diabetic Neuropathies [prevention & control]; 5. Diabetic Retinopathy [prevention & control]; 6. Glycated Hemoglobin [metabolism]; 7. Hyperglycemia [chemically induced]; 8. Hypoglycemic Agents [administration & dosage]; 9. Insulin [administration & dosage]; 10. Ketosis [chemically induced]; 11. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus | You are a research assistant. Based on the question please provide appropriate answers |
1. *Diet, Reducing; 2. *Exercise; 3. *Models, Psychological; 4. *Weight Loss; 5. Health Behavior; 6. Obesity [psychology, *therapy]; 7. Overweight [psychology, therapy]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Transtheoretical model stages of change for dietary and physical exercise modification in weight loss management for overweight and obese adults | You are a research assistant. Based on the question please provide appropriate answers |
1. *Mortality; 2. Calcitriol [*therapeutic use]; 3. Cause of Death; 4. Cholecalciferol [*therapeutic use]; 5. Dietary Supplements; 6. Ergocalciferols [*therapeutic use]; 7. Hydroxycholecalciferols [*therapeutic use]; 8. Randomized Controlled Trials as Topic; 9. Vitamins [*therapeutic use]; | Provide MESH terms for the study
Vitamin D supplementation for prevention of mortality in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. *Asthenopia; 2. *Drug-Related Side Effects and Adverse Reactions; 3. Eyeglasses; 4. Light; 5. *Melatonin; 6. Sleep; | Provide MESH terms for the study
Blue‐light filtering spectacle lenses for visual performance, sleep, and macular health in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cataract [complications]; 2. *Cataract Extraction [adverse effects]; 3. Lasers; 4. *Macular Edema [etiology]; 5. *Phacoemulsification [adverse effects, methods]; | Provide MESH terms for the study
Laser‐assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. *Anti-Bacterial Agents [adverse effects]; 2. *Conjunctivitis, Bacterial [drug therapy]; 3. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Antibiotics versus placebo for acute bacterial conjunctivitis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cataract; 2. *Glaucoma [surgery]; 3. Intraocular Pressure; 4. Quality of Life; 5. Randomized Controlled Trials as Topic; 6. *Trabeculectomy [methods]; | Provide MESH terms for the study
Device‐modified trabeculectomy for glaucoma | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cataract Extraction [adverse effects]; 2. *Glaucoma [surgery]; 3. Intraocular Pressure; 4. *Phacoemulsification [adverse effects, methods]; 5. Quality of Life; | Provide MESH terms for the study
Lens extraction versus laser peripheral iridotomy for acute primary angle closure | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticoagulants [therapeutic use]; 2. China; 3. *Retinal Artery Occlusion [therapy]; 4. *Tissue Plasminogen Activator [therapeutic use]; | Provide MESH terms for the study
Interventions for acute non‐arteritic central retinal artery occlusion | You are a research assistant. Based on the question please provide appropriate answers |
1. Capsule Opacification; 2. *Cataract Extraction; 3. *Lenses, Intraocular; 4. *Presbyopia [surgery]; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Trifocal intraocular lenses versus bifocal intraocular lenses after cataract extraction among participants with presbyopia | You are a research assistant. Based on the question please provide appropriate answers |
1. *Glaucoma; 2. *Glaucoma, Angle-Closure [surgery]; 3. Intraocular Pressure; 4. Quality of Life; 5. Vision Disorders; 6. Visual Fields; | Provide MESH terms for the study
Iridotomy to slow progression of visual field loss in angle‐closure glaucoma | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [therapeutic use]; 2. *Cataract [drug therapy]; 3. *Cataract Extraction [adverse effects]; 4. *Endophthalmitis [drug therapy, etiology, surgery]; 5. Randomized Controlled Trials as Topic; 6. Vitrectomy [adverse effects, methods]; | Provide MESH terms for the study
Early vitrectomy for exogenous endophthalmitis following surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [therapeutic use]; 2. Dexamethasone [therapeutic use]; 3. *Endophthalmitis [drug therapy]; 4. *Eye Diseases; 5. *Retinal Detachment; 6. Steroids [therapeutic use]; | Provide MESH terms for the study
Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones; 2. Antibodies, Monoclonal, Humanized [adverse effects]; 3. *Giant Cell Arteritis [drug therapy]; 4. Recurrence; | Provide MESH terms for the study
Tocilizumab for giant cell arteritis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cataract; 2. *Cataract Extraction [adverse effects, methods]; 3. *Endophthalmitis; 4. Lens Implantation, Intraocular [methods]; 5. Visual Acuity; | Provide MESH terms for the study
Immediate sequential bilateral surgery versus delayed sequential bilateral surgery for cataracts | You are a research assistant. Based on the question please provide appropriate answers |
1. *Conjunctivitis [drug therapy]; 2. *Conjunctivitis, Viral [drug therapy]; 3. Cyclosporine [therapeutic use]; 4. Dexamethasone; 5. Fluorometholone; 6. Ganciclovir; 7. *Keratoconjunctivitis [drug therapy]; 8. Levofloxacin; 9. Lubricant Eye Drops [therapeutic use]; 10. Povidone-Iodine; 11. Tacrolimus; 12. Trifluridine; | Provide MESH terms for the study
Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Quality of Life; 2. Randomized Controlled Trials as Topic; 3. Retina; 4. *Retinal Detachment [surgery]; 5. Scleral Buckling [adverse effects]; 6. Vitrectomy; | Provide MESH terms for the study
Pneumatic retinopexy versus scleral buckle for repairing simple rhegmatogenous retinal detachments | You are a research assistant. Based on the question please provide appropriate answers |
1. *Glaucoma [surgery]; 2. *Glaucoma, Open-Angle [surgery]; 3. Intraocular Pressure; 4. Sclera; 5. *Trabeculectomy; | Provide MESH terms for the study
Fornix‐based versus limbal‐based conjunctival trabeculectomy flaps for glaucoma | You are a research assistant. Based on the question please provide appropriate answers |
1. Capsule Opacification [etiology, *prevention & control]; 2. Cataract; 3. *Cataract Extraction; 4. Lens Capsule, Crystalline; 5. *Lens Implantation, Intraocular; 6. *Lenses, Intraocular; 7. Phacoemulsification; 8. Postoperative Complications [*prevention & control]; 9. *Prosthesis Design; | Provide MESH terms for the study
Intraocular lens optic edge design for the prevention of posterior capsule opacification after cataract surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cataract; 2. *Cataract Extraction; 3. *Glaucoma [surgery]; 4. *Trabeculectomy; 5. Wound Healing; | Provide MESH terms for the study
Adjunctive modulation of wound healing during cataract surgery to promote survival of a previous trabeculectomy | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Confidence Intervals; 3. Contrast Sensitivity; 4. Disease Progression; 5. Low-Level Light Therapy [adverse effects, *methods]; 6. Macular Degeneration [*radiotherapy]; 7. Outcome Assessment, Health Care; 8. Placebos; 9. Quality of Life; 10. Randomized Controlled Trials as Topic; 11. Treatment Outcome; 12. Visual Acuity; | Provide MESH terms for the study
Photobiomodulation for non‐exudative age‐related macular degeneration | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Confidence Intervals; 3. Disease Progression; 4. Epiretinal Membrane [*surgery]; 5. *Visual Acuity; 6. *Watchful Waiting; | Provide MESH terms for the study
Surgery for idiopathic epiretinal membrane | You are a research assistant. Based on the question please provide appropriate answers |
1. Chronic Disease; 2. Disease Progression; 3. Glaucoma, Angle-Closure [drug therapy, *surgery]; 4. Lens, Crystalline [*surgery]; 5. Phacoemulsification [adverse effects, *methods]; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; 8. Visual Acuity; | Provide MESH terms for the study
Lens extraction for chronic angle‐closure glaucoma | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Chronic Disease; 3. Glaucoma, Angle-Closure [drug therapy, *surgery]; 4. Intraocular Pressure; 5. Iris [*surgery]; 6. Laser Therapy [*methods, statistics & numerical data]; 7. Lasers, Gas [therapeutic use]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Laser peripheral iridoplasty for chronic angle closure | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Glaucoma, Open-Angle [*surgery]; 3. *Phacoemulsification; 4. Randomized Controlled Trials as Topic; 5. Trabecular Meshwork [*surgery]; 6. Trabeculectomy [*instrumentation, methods]; | Provide MESH terms for the study
Ab interno trabecular bypass surgery with Trabectome for open‐angle glaucoma | You are a research assistant. Based on the question please provide appropriate answers |
1. Astigmatism [surgery]; 2. Corneal Wavefront Aberration [*surgery]; 3. Hyperopia [surgery]; 4. Keratectomy, Subepithelial, Laser-Assisted [adverse effects, *methods]; 5. Keratomileusis, Laser In Situ [adverse effects, *methods]; 6. Lasers, Excimer [*therapeutic use]; 7. Myopia [surgery]; 8. Photorefractive Keratectomy [adverse effects, *methods]; 9. Randomized Controlled Trials as Topic; 10. Treatment Outcome; 11. Visual Acuity; | Provide MESH terms for the study
Wavefront excimer laser refractive surgery for adults with refractive errors | You are a research assistant. Based on the question please provide appropriate answers |
1. Choroidal Neovascularization [epidemiology]; 2. Clinical Trials, Phase II as Topic; 3. Disease Progression; 4. Fenretinide [adverse effects, *therapeutic use]; 5. Geographic Atrophy [*drug therapy, etiology, *prevention & control]; 6. Incidence; 7. Macular Degeneration [*complications]; 8. Phenyl Ethers [adverse effects, *therapeutic use]; 9. Placebos [therapeutic use]; 10. Propanolamines [adverse effects, *therapeutic use]; 11. Randomized Controlled Trials as Topic; 12. Visual Acuity [drug effects]; 13. *Watchful Waiting; | Provide MESH terms for the study
Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age‐related macular degeneration | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [therapeutic use]; 2. Collagen [*radiation effects]; 3. Eye Infections, Bacterial [drug therapy, *radiotherapy]; 4. Keratitis [drug therapy, microbiology, *radiotherapy]; 5. Photosensitizing Agents [*therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Riboflavin [*therapeutic use]; 8. Ultraviolet Therapy [adverse effects, *methods]; 9. Visual Acuity; | Provide MESH terms for the study
Corneal collagen cross‐linking for bacterial infectious keratitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Angiogenesis Inhibitors [*administration & dosage, economics]; 2. Bevacizumab [administration & dosage, economics]; 3. Bias; 4. Drug Administration Schedule; 5. Endophthalmitis [epidemiology, etiology]; 6. Intravitreal Injections [adverse effects]; 7. Macular Degeneration [*drug therapy, pathology]; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; 10. Ranibizumab [administration & dosage, economics]; 11. Receptors, Vascular Endothelial Growth Factor [administration & dosage]; 12. Recombinant Fusion Proteins [administration & dosage, economics]; 13. Retina [drug effects]; 14. Vascular Endothelial Growth Factor A [*antagonists & inhibitors]; 15. Visual Acuity [*drug effects]; | Provide MESH terms for the study
Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration | You are a research assistant. Based on the question please provide appropriate answers |
1. Astigmatism [*surgery]; 2. Keratomileusis, Laser In Situ [instrumentation, *methods]; 3. Myopia [*surgery]; 4. Randomized Controlled Trials as Topic; 5. Visual Acuity; | Provide MESH terms for the study
Laser‐assisted in‐situ keratomileusis (LASIK) with a mechanical microkeratome compared to LASIK with a femtosecond laser for LASIK in adults with myopia or myopic astigmatism | You are a research assistant. Based on the question please provide appropriate answers |
1. Dry Eye Syndromes [etiology, therapy]; 2. Intense Pulsed Light Therapy [*methods]; 3. Meibomian Gland Dysfunction [complications, *therapy]; 4. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction | You are a research assistant. Based on the question please provide appropriate answers |
1. *Glaucoma Drainage Implants; 2. Cataract Extraction; 3. Glaucoma, Open‐Angle [*surgery]; 4. Randomized Controlled Trials as Topic; 5. Trabeculectomy [*methods]; | Provide MESH terms for the study
Ab interno trabecular bypass surgery with Schlemm´s canal microstent (Hydrus) for open angle glaucoma | You are a research assistant. Based on the question please provide appropriate answers |
1. *Quality of Life; 2. Depression [therapy]; 3. Randomized Controlled Trials as Topic; 4. Self Efficacy; 5. Vision, Low [*psychology, *rehabilitation]; | Provide MESH terms for the study
Low vision rehabilitation for better quality of life in visually impaired adults | You are a research assistant. Based on the question please provide appropriate answers |
1. *Visual Acuity [physiology]; 2. Astigmatism [etiology, surgery]; 3. Keratoplasty, Penetrating [*methods]; 4. Lens Implantation, Intraocular [*methods]; 5. Lenses, Intraocular; 6. Phacoemulsification [*methods]; 7. Postoperative Complications [epidemiology]; 8. Randomized Controlled Trials as Topic; 9. Refraction, Ocular [physiology]; | Provide MESH terms for the study
Toric intraocular lens versus limbal relaxing incisions for corneal astigmatism after phacoemulsification | You are a research assistant. Based on the question please provide appropriate answers |
1. Randomized Controlled Trials as Topic; 2. Retinal Detachment [*surgery]; 3. Retinal Perforations [*surgery]; 4. Scleral Buckling [*methods]; 5. Treatment Outcome; 6. Vitrectomy [*methods]; | Provide MESH terms for the study
Pars plana vitrectomy combined with scleral buckle versus pars plana vitrectomy for giant retinal tear | You are a research assistant. Based on the question please provide appropriate answers |
1. Cyclosporine [*administration & dosage, therapeutic use]; 2. Dry Eye Syndromes [*drug therapy]; 3. Lubricant Eye Drops [*administration & dosage, therapeutic use]; 4. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Topical cyclosporine A therapy for dry eye syndrome | You are a research assistant. Based on the question please provide appropriate answers |
1. Amblyopia [*therapy]; 2. Atropine [*therapeutic use]; 3. Occlusive Dressings; 4. Ophthalmic Solutions [*therapeutic use]; 5. Randomized Controlled Trials as Topic; 6. Visual Acuity; | Provide MESH terms for the study
Conventional occlusion versus pharmacologic penalization for amblyopia | You are a research assistant. Based on the question please provide appropriate answers |
1. Corneal Stroma [*surgery]; 2. Corneal Transplantation [methods]; 3. Keratoconus [*surgery]; 4. Prostheses and Implants; 5. Prosthesis Implantation [*methods]; | Provide MESH terms for the study
Intrastromal corneal ring segments for treating keratoconus | You are a research assistant. Based on the question please provide appropriate answers |
1. *Glaucoma Drainage Implants; 2. Glaucoma [surgery, *therapy]; 3. Mitomycin [*therapeutic use]; 4. Randomized Controlled Trials as Topic; 5. Treatment Outcome; | Provide MESH terms for the study
Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma | You are a research assistant. Based on the question please provide appropriate answers |
1. Antihypertensive Agents [administration & dosage]; 2. Combined Modality Therapy [methods]; 3. *Glaucoma Drainage Implants; 4. Glaucoma, Open-Angle [*surgery]; 5. Ocular Hypertension [therapy]; 6. Ophthalmic Solutions [administration & dosage]; 7. Phacoemulsification; 8. Randomized Controlled Trials as Topic; 9. *Stents; 10. *Trabecular Meshwork; | Provide MESH terms for the study
Ab interno trabecular bypass surgery with iStent for open‐angle glaucoma | You are a research assistant. Based on the question please provide appropriate answers |
1. *Glaucoma Drainage Implants [adverse effects]; 2. Aqueous Humor; 3. Ciliary Body [*surgery]; 4. Endoscopy; 5. Glaucoma [*surgery]; 6. Intraocular Pressure; 7. Laser Coagulation [adverse effects, *methods]; 8. Lasers, Solid‐State [therapeutic use]; 9. Randomized Controlled Trials as Topic; 10. Visual Acuity; | Provide MESH terms for the study
Cyclodestructive procedures for refractory glaucoma | You are a research assistant. Based on the question please provide appropriate answers |
1. *Scleral Buckling [adverse effects, statistics & numerical data]; 2. *Vitrectomy [adverse effects, statistics & numerical data]; 3. Postoperative Complications; 4. Quality of Life; 5. Randomized Controlled Trials as Topic; 6. Recurrence; 7. Retinal Detachment [etiology, *surgery]; 8. Retinal Perforations [*complications]; 9. Treatment Outcome; 10. Visual Acuity; | Provide MESH terms for the study
Pars plana vitrectomy versus scleral buckling for repairing simple rhegmatogenous retinal detachments | You are a research assistant. Based on the question please provide appropriate answers |
1. *Endoscopy; 2. Combined Modality Therapy [methods]; 3. Glaucoma, Angle‐Closure [*surgery]; 4. Glaucoma, Open‐Angle [*surgery]; 5. Laser Coagulation [*methods]; 6. Phacoemulsification; | Provide MESH terms for the study
Endoscopic cyclophotocoagulation (ECP) for open angle glaucoma and primary angle closure | You are a research assistant. Based on the question please provide appropriate answers |
1. Age Factors; 2. Cataract Extraction [*adverse effects, *economics, statistics & numerical data]; 3. Cost Savings; 4. Diagnostic Tests, Routine [*economics]; 5. Hospitalization [statistics & numerical data]; 6. Intraoperative Complications [epidemiology, prevention & control]; 7. Postoperative Complications [epidemiology, prevention & control]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Routine preoperative medical testing for cataract surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. Macular Edema [*drug therapy, etiology]; 2. Off-Label Use; 3. Tumor Necrosis Factor-alpha [*antagonists & inhibitors]; 4. Uveitis [*complications]; | Provide MESH terms for the study
Anti‐tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non‐infectious uveitis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Glaucoma Drainage Implants [adverse effects]; 2. Glaucoma [*therapy]; 3. Intraocular Pressure; 4. Trabeculectomy; | Provide MESH terms for the study
Subconjunctival draining minimally‐invasive glaucoma devices for medically uncontrolled glaucoma | You are a research assistant. Based on the question please provide appropriate answers |
1. *Descemet Stripping Endothelial Keratoplasty [adverse effects]; 2. Cell Count; 3. Corneal Diseases [*surgery]; 4. Corneal Transplantation; 5. Descemet Membrane [*surgery]; 6. Endothelial Cells [cytology]; 7. Fuchs' Endothelial Dystrophy [*surgery]; 8. Non‐Randomized Controlled Trials as Topic; 9. Postoperative Complications [etiology]; 10. Visual Acuity; | Provide MESH terms for the study
Descemet's membrane endothelial keratoplasty (DMEK) versus Descemet's stripping automated endothelial keratoplasty (DSAEK) for corneal endothelial failure | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cataract Extraction [adverse effects, statistics & numerical data]; 2. *Lenses, Intraocular; 3. *Light; 4. Color; 5. Contrast Sensitivity; 6. Filtration [*instrumentation]; 7. Macula Lutea [*radiation effects]; 8. Macular Degeneration [*prevention & control]; 9. Postoperative Complications [*prevention & control]; 10. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Blue‐light filtering intraocular lenses (IOLs) for protecting macular health | You are a research assistant. Based on the question please provide appropriate answers |
1. *Reading; 2. *Sensory Aids; 3. Eyeglasses; 4. Lenses; 5. Macular Degeneration [complications]; 6. Optical Devices [*standards]; 7. Randomized Controlled Trials as Topic; 8. Vision, Low [etiology, *rehabilitation]; 9. Visual Acuity; 10. Visually Impaired Persons [*rehabilitation]; | Provide MESH terms for the study
Reading aids for adults with low vision | You are a research assistant. Based on the question please provide appropriate answers |
1. *Computer Terminals; 2. *Eyeglasses; 3. Asthenopia [etiology, *prevention & control]; 4. Ergonomics; 5. Headache [prevention & control]; 6. Randomized Controlled Trials as Topic; 7. Refractive Errors [*therapy]; | Provide MESH terms for the study
Optical correction of refractive error for preventing and treating eye symptoms in computer users | You are a research assistant. Based on the question please provide appropriate answers |
1. *Suture Techniques; 2. Strabismus [*surgery]; 3. Treatment Outcome; | Provide MESH terms for the study
Adjustable versus non‐adjustable sutures for strabismus | You are a research assistant. Based on the question please provide appropriate answers |
1. *Quality Improvement [economics]; 2. Costs and Cost Analysis; 3. Diabetes Mellitus, Type 1 [*complications]; 4. Diabetes Mellitus, Type 2 [*complications]; 5. Diabetic Retinopathy [*diagnosis]; 6. Patient Compliance [psychology, *statistics & numerical data]; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Interventions to increase attendance for diabetic retinopathy screening | You are a research assistant. Based on the question please provide appropriate answers |
1. Angiogenesis Inhibitors [*administration & dosage, adverse effects]; 2. Aptamers, Nucleotide [*administration & dosage, adverse effects]; 3. Bevacizumab [*administration & dosage, adverse effects]; 4. Combined Modality Therapy; 5. Cryotherapy [methods]; 6. Intravitreal Injections; 7. Laser Therapy [methods]; 8. Randomized Controlled Trials as Topic; 9. Ranibizumab [*administration & dosage, adverse effects]; 10. Retinal Detachment [prevention & control]; 11. Retinopathy of Prematurity [*drug therapy]; 12. Vascular Endothelial Growth Factor A [*antagonists & inhibitors]; | Provide MESH terms for the study
Anti‐vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity | You are a research assistant. Based on the question please provide appropriate answers |
1. *Oculomotor Muscles; 2. Ophthalmoplegia [*complications]; 3. Postoperative Complications; 4. Randomized Controlled Trials as Topic; 5. Strabismus [etiology, *surgery]; | Provide MESH terms for the study
Surgical interventions for vertical strabismus in superior oblique palsy | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cataract Extraction; 2. *Developing Countries; 3. *Health Services Accessibility [statistics & numerical data]; 4. *Rural Health Services; 5. Cataract [complications]; 6. China; 7. Patient Education as Topic; 8. Randomized Controlled Trials as Topic; 9. Referral and Consultation [statistics & numerical data]; 10. Vision Disorders; | Provide MESH terms for the study
Interventions to improve access to cataract surgical services and their impact on equity in low‐ and middle‐income countries | You are a research assistant. Based on the question please provide appropriate answers |
1. *Vitreous Body; 2. Fibrinolysin [*administration & dosage, adverse effects]; 3. Fibrinolytic Agents [*administration & dosage, adverse effects]; 4. Intravitreal Injections; 5. Peptide Fragments [*administration & dosage, adverse effects]; 6. Randomized Controlled Trials as Topic; 7. Retinal Diseases [*drug therapy]; 8. Time Factors; 9. Tissue Adhesions [drug therapy]; 10. Visual Acuity; 11. Vitrectomy; 12. Vitreous Detachment [drug therapy, etiology]; | Provide MESH terms for the study
Ocriplasmin for symptomatic vitreomacular adhesion | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cataract; 2. *Surgical Wound; 3. Astigmatism [*etiology]; 4. Corneal Edema [etiology]; 5. Corneal Pachymetry; 6. Phacoemulsification [adverse effects, *methods]; 7. Postoperative Complications [*etiology]; 8. Randomized Controlled Trials as Topic; 9. Visual Acuity; | Provide MESH terms for the study
Different‐sized incisions for phacoemulsification in age‐related cataract | You are a research assistant. Based on the question please provide appropriate answers |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.